Skip to main content
. 2021 Nov 29;13(11):e20004. doi: 10.7759/cureus.20004

Figure 5. PET scan demonstrating resolution of lesion seen in Figure 3 after 9 months of immunotherapy with pembrolizumab.

Figure 5

PET, positron emission tomography